EC Number   |
Application |
Reference |
|---|
   3.6.4.13 | drug development |
enzyme p68 is a drug target in the treatment of cancer, e.g. breast cancer |
757299 |
| 3.6.4.13 | drug development |
the enzyme is a target for anti-HCV drug development |
669138 |
| 3.6.4.13 | drug development |
the enzyme is a target for development of specific antiviral inhibitors |
670078 |
| 3.6.4.13 | drug development |
the multifunctional NS3 protein from Dengue virus is a target for the design of antiviral inhibitors |
695648 |
| 3.6.4.13 | medicine |
analysis of tumorigenic function of p68 in association with its targeting potential for the treatment of breast cancer |
757299 |
| 3.6.4.13 | medicine |
DDX4 can serve as a useful and highly specific biomarker for the diagnosis of germ cell tumors |
691843 |
| 3.6.4.13 | medicine |
mutation within hBrr2p can be linked to autosomal dominant retinitis pigmentosa |
711169 |
| 3.6.4.13 | pharmacology |
conservation of the NTP-binding pocket among viruses of the family Flaviviridae as potential for development of therapeutics |
690191 |
| 3.6.4.13 | pharmacology |
peptide inhibitors reproducing the structure of the autoregulatory motif as possibility to develop effective antivirals |
696133 |
